Rare Disease Innovation and Partnering Summit 2019

Topics

• Advancements in Gene Therapy that Are Tearing Down Barriers to Discovery in Rare Disease
• New Developments in Cures, Community, Collaboration and the Care Continuum for Patients and Caregivers
• Artificial Intelligence (AI) and Advanced Data Analytics — Reshaping Complex Diagnostics and Decision-Making in Rare Disease Drug Development
• Legislative Updates and New Initiatives within the FDA’s Orphan Drug Program

Who should Attend

• Rare Disease
• Market Access
• Commercial Strategy/Operations
• Orphan Drugs
• Early/Expanded Access
• Reimbursement
• Product Launch
• Launch Excellence
• Marketing
• Portfolio Management/Strategy
• Patient Advocacy
• Development
• Patient Support/Services
• Payer Strategy